Cost-Effectiveness of Voretigene Neparvovec for RPE65-mediated Inherited Retinal Degeneration in Germany

dc.contributor.authorUhrmann, Matthias Fritz
dc.contributor.authorLorenz, Birgit
dc.contributor.authorGissel, Christian
dc.date.accessioned2022-08-26T12:28:55Z
dc.date.available2022-08-26T12:28:55Z
dc.date.issued2020
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/7007
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-6458
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:330
dc.titleCost-Effectiveness of Voretigene Neparvovec for RPE65-mediated Inherited Retinal Degeneration in Germany
dc.typearticle
local.affiliationFB 02 - Wirtschaftswissenschaften
local.source.articlenumber17
local.source.journaltitleTranslational Vision Science & Technology
local.source.number9
local.source.urihttps://doi.org/10.1167/tvst.9.9.17
local.source.volume9

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1167_tvst.9.9.17.pdf
Größe:
778.14 KB
Format:
Adobe Portable Document Format
Beschreibung: